Global and United States Osteoarthritis Therapeutics Market Report & Forecast 2022-2028

This report studies Osteoarthritis Therapeutics market, the main role of Osteoarthritis Therapeutics is to relieve pain, and cannot slow the progress of osteoarthritis.
Market Analysis and Insights: Global and United States Osteoarthritis Therapeutics Market
This report focuses on global and United States Osteoarthritis Therapeutics market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Osteoarthritis Therapeutics market size is estimated to be worth US$ 6232.7 million in 2022 and is forecast to a readjusted size of US$ 8163.3 million by 2028 with a CAGR of 4.6% during the review period. Fully considering the economic change by this health crisis, by Type, Oral accounting for % of the Osteoarthritis Therapeutics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Medical Care was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Osteoarthritis Therapeutics market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global Osteoarthritis Therapeutics Scope and Market Size
Osteoarthritis Therapeutics market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Osteoarthritis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Osteoarthritis Therapeutics market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Oral
Injection
External
Segment by Application
Medical Care
Personal Care
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Pfizer
Johnson & Johnson
GlaxoSmithKline
Bayer
Eli Lilly
Novartis
Sanofi
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma